Lucchinetti CF , Bruck W , Parisi J , Scheithauer B , Rodriguez M , Lassmann H.Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination . Ann Neurol2000; 47: 707-717 .
2.
Aboul-Enein F , Rauschka H , Kornek B , Stadelmann C , Stefferl A , Bruck W , et al.Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases . J Neuropathol Exp Neurol2003; 62(1): 25-33 .
3.
Mahad DJ , Trebst C , Kivisakk P , Staugaitis SM , Tucky B , Wei T , et al.Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions . J Neuropathol Exp Neurol2004; 63(3): 262-273 .
4.
Pittock SJ MR , Achenbach SJ , Bitsh A , Bruck W , Lassmann H , Rodriguez M , Parisi JE , Scheithauer BW , Lucchinetti CF.The clinical course of biopsy-proven demyelinating disease and comparison with population-based MS prevalence cohort [Abstract]. American Committee for Treatment and Research in MS (ACTRIMS)2003.
5.
Lucchinetti C , Mandler R , Weinshenker B , Wingerchuk D , Lassmann H.Humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica . Neurology2000; 54(7; Suppl 3): A259-A259 .
6.
Stadelmann C , Ludwin SK , Tabira T , Guseo A , Lucchinetti C , Brück W , et al.Hypoxic preconditioning explains concentric lesions in Balo’s type of multiple sclerosis . Brain2004; submitted.
7.
Lennon VA , Wingerchuk DM , Kryzer TJ , Pittock SJ , Lucchinetti CF , Fujihara K , et al.A serum autoantibody marker of neuromyelitis optica . Lancet2004; in press.
8.
Keegan M , Konig F , Bitsch A , Bruck W , Lassmann H , Panitch H , et al.Multiple sclerosis pathological subtype predicts response to therapeutic plasma exchange . Neurology2004; 62(Suppl 5): 7-7 .
9.
Lucchinetti CF , Altintas A , Wegner C , Erickson BJ , Lassmann H , Bruck W.Magnetic resonance imaging correlates of multiple sclerosis pathologic subtypes . Ann Neurol2003; (Suppl 7): 54: 67-67 .